Trials / Completed
CompletedNCT00490048
Assessment of Pulmonary Involvement inUlcerative Colitis by Induced Sputum
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 20 (estimated)
- Sponsor
- Hillel Yaffe Medical Center · Other Government
- Sex
- All
- Age
- 18 Years – 75 Years
- Healthy volunteers
- Not accepted
Summary
Ulcerative colitis is a systemic disease we assume that extra intestinal involvement as we describein our study( Fireman Z, Osipov A, Kivity S, Kopelman Y, Sternberg A Fireman E: Assessment of pulmonary involvement in Crohn's disease by induced sputum. Am J Gastroenterol 2000;95(30):730-734. )
Detailed description
Twenty Ulcerative colitis patients and 20 control subjects (all nonsmokers) without respiratory symptoms will be tested. The induce sputum by 20' inhalation of 3.5% saline using ultrasonic nebulizer. Samples will studied by differential counts of 200 cells on cytopreps stained by Giemsa. T-lymphocyte subset analyses were done by FACS using three monoclonal antibodies: CD3 = total T cells, CD4 = T helper cells, and CD8 = T suppressor-cytotoxic cells. CD4/CD8 \>2.5 was considered abnormal.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| PROCEDURE | Induced sputum (inhalation of 3.5% saline) |
Timeline
- Start date
- 2007-06-01
- Completion
- 2007-06-01
- First posted
- 2007-06-22
- Last updated
- 2007-06-22
Source: ClinicalTrials.gov record NCT00490048. Inclusion in this directory is not an endorsement.